BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Receives $13.63 Average Price Target from Brokerages theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Receives $13.63 Average Target Price from Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Needham & Company LLC reissued their buy rating on shares of BioCryst Pharmaceuticals (NASDAQ:BCRX – Free Report) in a research note issued to investors on Monday morning, Benzinga reports. The firm currently has a $12.00 price objective on the biotechnology company’s stock. Other equities research analysts have also issued research reports about the stock. Royal […]
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) has been assigned a consensus rating of “Buy” from the eight analysts that are currently covering the firm, Marketbeat Ratings reports. Eight research analysts have rated the stock with a buy recommendation. The average 12 month price target among brokerages that have covered the stock in the […]
Analysts Set BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Price Target at $13.63 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.